London, September 2, 2013 – Advent International, one of the largest and most experienced firms dedicated solely to private equity, today announced that it has appointed Hanspeter Spek to its Operating Partner Programme.
An executive with extensive operational experience in the global pharmaceuticals and healthcare industries, Mr Spek will advise and work closely with Advent’s healthcare team to identify attractive investment opportunities and generate post-investment value in the areas of pharmaceuticals and pharmaceuticals-related services globally.
Mr Spek’s industry expertise spans several decades. Most recently he served as Sanofi’s President of Global Operations, having held a variety of positions since he joined the firm in 1985 as Marketing Director of Sanofi Pharma GmbH, the company’s German subsidiary. He progressed through the Group serving in a number of roles in Germany and France before being named Senior Vice President Europe following the merger with Synthélabo in 1999. He was Executive Vice President, International Operations from October 2000 until January 2003, when he was appointed Executive Vice President of Worldwide operations of Sanofi-Synthélabo, later becoming Sanofi.
Before joining Sanofi, Mr Spek worked at Pfizer International where he held various marketing and sales positions before becoming Marketing Director for the German subsidiary.
Tom Allen, Advent International said: “We are delighted to welcome Hanspeter Spek to our Operating Partner Programme. Advent is an active investor in the healthcare sector and pharmaceuticals is a key focus for the team, as evidenced by Advent’s recent acquisition of Mediq, a leading business delivering pharmaceuticals, medical devices and related care services. Hanspeter’s operational and financial experience gained from working within leading global pharmaceutical businesses will further enhance our capability to pursue opportunities in the sector and support our portfolio companies globally.”
Commenting on his new role, Hanspeter Spek said: “Advent has an excellent track record in the healthcare sector with a diversified portfolio of investments. I look forward to sharing my industry knowledge and working closely with the Advent team to acquire and grow leading companies in the sector.”
Advent International has been an active investor in the healthcare sector for over 20 years and has funded over 30 companies worldwide. Most recently Advent acquired Mediq, a leading business delivering pharmaceuticals, medical devices and related care services. Other recent investments include Connolly Inc. a leading technology-enabled provider of recovery audit services and CARE Hospitals, a multi-speciality hospital chain in India.
Advent’s Operating Partner Programme, is a long-established and successful element of the firm’s highly operational approach to investing. The programme includes over 60 senior industry executives, many of whom have been involved in multiple Advent investments. These executives typically assist in activities such as finding attractive investment opportunities, conducting due diligence, and creating and driving value creation plans for Advent’s portfolio companies.
About Advent International
Founded in 1984, Advent International is one of the largest and most experienced global investors dedicated solely to private equity. Since inception, the firm has invested in more than 280 buyout transactions in 36 countries, achieving over 230 full or partial exits, and today has €25.3 billion in assets under management. With offices on four continents, Advent has established a globally integrated team of over 170 investment professionals across North America, Europe, Latin America and Asia. The firm focuses on growth and traditional buyout and strategic repositioning transactions across five core sectors, including business and financial services; healthcare; industrial; retail, consumer and leisure; and technology, media and telecoms. After 29 years dedicated to international investing, Advent remains committed to partnering with management teams to deliver sustained revenue and earnings growth for portfolio
For more information, visit www.adventinternational.com.